Cited by 20Rheumatoid Arthritis Research and TherapiesInflammatory mediators and NSAID effectsNatural Compounds in Disease Treatment

Flufenamic acid in rheumatoid arthritis

Open access
Rajan, K.T, Hill, A.G, Barr, A, Whitwell, E·1967·Annals of the Rheumatic Diseases

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/ard.26.1.43

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Flufenamic acid (FFA) is a NSAID that has been specifically used to treat rheumatoid arthritis.

    “FFA is a NSAID that has been specifically used to treat rheumatoid arthritis [6], although its potential as an antifungal agent has not been previously defined.”
  • FFA might be an effective adjunctive antifungal agent when combined with FLU, AmB and CAS if administered at standard doses.

    “According to these pharmacokinetic parameters, FFA might be an effective adjunctive antifungal agent when combined with FLU, AmB and CAS if administered at standard doses (normal dosage varies from 200 mg to 600 mg per day) [6].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited by

Sorted by citations

Authors
Rajan, K. T., Hill, A. G., Barr, A., & Whitwell, E.
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
1967-01
Volume
26
Issue
1
Pages
43-46
ISSN
0003-4967 (ISSN-L)
OpenAlex
W1978727112
Cited by
20
References
6
Citations by year
2024: 1 · 2020: 1 · 2019: 2 · 2017: 1 · 2016: 1 · 2013: 2
FWCI
2.76
Type
journal article
Language
en
Open access
Locations
  • Annals of the Rheumatic Diseases (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
  • Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
Keywords
flufenamic acid, rheumatoid arthritis, anti-inflammatory agents, phenylbutazone, aspirin, drug comparison, clinical trials
MeSH terms
Anti-Inflammatory Agents, Arthritis, Rheumatoid, Aspirin, Blood Sedimentation, Clinical Trials as Topic, Flufenamic Acid, Humans, Phenylbutazone, ortho-Aminobenzoates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review